Deferoxamine mesylate is an iron-chelating agent and polyaminocarboxylic acid derivative primarily used to treat iron overload conditions, including hemochromatosis and hemosiderosis. By binding to excess… Read more



















Deferoxamine mesylate is an iron-chelating agent and polyaminocarboxylic acid derivative primarily used to treat iron overload conditions, including hemochromatosis and hemosiderosis. By binding to excess iron in the body, this compound facilitates its excretion, which is vital for patients managing chronic iron accumulation from blood transfusions or genetic factors. This category features a comprehensive range of related compounds, including pharmacopeial and non-pharmacopeial impurities, degradation products, and stable isotope-labelled standards. These materials are essential for pharmaceutical laboratories conducting rigorous analytical testing, impurity profiling, and method validation to ensure the quality and consistency of the active pharmaceutical ingredient. By utilizing these precise reference standards, researchers and quality control professionals can effectively monitor product purity and accurately identify potential impurities throughout the development and manufacturing processes.